UBX – unity biotechnology, inc. (US:NASDAQ)
Stock Stats
News
Unity Biotechnology, Inc. (NASDAQ: UBX) had its price target lowered by analysts at Chardan Capital from $6.00 to $4.00. They now have a "buy" rating on the stock.
Unity Biotechnology, Inc. (NASDAQ: UBX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $6.00 price target on the stock.
Unity Biotechnology, Inc. (NASDAQ: UBX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
UNITY Biotechnology Appoints Industry Leader and Ophthalmology Expert Yehia Hashad, M.D., to the Board of Directors
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates [Yahoo! Finance]
Form 8-K Unity Biotechnology, For: Apr 03
Form 144 Unity Biotechnology, Filed by: Nguyen Alexander Hieu
Form 4 Unity Biotechnology, For: Apr 02 Filed by: Nguyen Alexander Hieu
Form 144 Unity Biotechnology, Filed by: Sullivan Lynne Marie
Form 4 Unity Biotechnology, For: Apr 02 Filed by: Sullivan Lynne Marie
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.